Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.

  • Presentation

Getting the Most from Alopecia Pathology Reports

Description

The speaker explains how to get the most out of alopecia pathology reports by reading them carefully and understanding what each section contributes. They emphasize that strong clinical information—such as pattern, location, and duration of hair loss—is essential because pathology findings must be interpreted in context. The talk highlights how wording in the diagnosis and comments reflects the pathologist’s certainty, with phrases like “diagnostic of,” “consistent with,” and “suggestive of” carrying different levels of confidence. The microscopic description should include details such as total follicle count, follicular size, sebaceous glands, inflammation, and fibrosis, since increased telogen hairs alone do not prove telogen effluvium and can appear in other conditions. They also stress the importance of the gross description: scalp biopsies should be deep, 4 mm punches, because shallow or fragmented specimens can lead to misdiagnosis, especially confusing non-scarring with scarring alopecia. Through cases involving chemotherapy-induced alopecia and a shallow biopsy misread as lichen planopilaris, the speaker shows that careful wording, adequate biopsy technique, and communication with the pathologist are key to accurate diagnosis and management.

View more

Conclusions

  • Alopecia pathology reports are most useful when clinicians provide detailed history, because clinicopathologic correlation can dramatically change interpretation.
  • The exact wording of the diagnosis and comment matters, since terms like 'suggestive of' or 'not diagnostic' indicate limited certainty rather than a definitive answer.
  • Microscopic descriptions should include follicle count, follicle size, sebaceous glands, inflammation, fibrosis, and other features, not just the final diagnosis.
  • An increased number of telogen hairs alone does not prove telogen effluvium, because similar findings can occur in other alopecias such as androgenetic alopecia.
  • A low follicular count should raise concern for scarring alopecia, including traction alopecia or permanent chemotherapy-induced alopecia, even when the biopsy looks non-scarring.
  • The type and depth of inflammation are critical for classification, especially in distinguishing neutrophilic and lymphocytic scarring alopecias.
  • Gross description is important because biopsy size, depth, and sectioning method strongly affect whether the specimen is adequate for diagnosis.
  • Shallow or tiny scalp biopsies can be misleading and may falsely suggest scarring alopecia or other diagnoses.
  • Superficial inflammation in androgenetic alopecia can mimic lichen planopilaris, so overcalling scarring alopecia is a real risk when the biopsy is inadequate.
  • When pathology and clinical findings do not match, the report should be questioned, the slides reviewed, and re-biopsy considered if needed.
  • Sperling LC: Arch Dermatol 1999.